Terms: = Liver cancer AND TFE3, RCCP2, 7030, ENSG00000068323, TFEA AND Treatment
11 results:
1. Machine Learning Models in Prediction of treatment Response After Chemoembolization with MRI Clinicoradiomics Features.
İnce O; Önder H; Gençtürk M; Cebeci H; Golzarian J; Young S
Cardiovasc Intervent Radiol; 2023 Dec; 46(12):1732-1742. PubMed ID: 37884802
[TBL] [Abstract] [Full Text] [Related]
2. Nomogram to predict liver surgery-specific complications for hepatocellular carcinoma: A multicenter study.
Qi W; Dai J; Qiu Z; Wu Y; Wen T; Xie F; Gao F; Zhang Y; Li C
Eur J Surg Oncol; 2023 Dec; 49(12):107119. PubMed ID: 37871467
[TBL] [Abstract] [Full Text] [Related]
3. Adapted time-varying covariates Cox model for predicting future cirrhosis development performs well in a large hepatitis C cohort.
Beste LA; Zhang X; Su GL; Van T; Ioannou GN; Oselio B; Tincopa M; Liu B; Singal AG; Zhu J; Waljee AK
BMC Med Inform Decis Mak; 2021 Dec; 21(1):347. PubMed ID: 34903225
[TBL] [Abstract] [Full Text] [Related]
4. Hepatic perivascular epithelioid cell tumor: Clinicopathological analysis of 26 cases with emphasis on disease management and prognosis.
Zhang S; Yang PP; Huang YC; Chen HC; Chen DL; Yan WT; Yang NN; Li Y; Li N; Feng ZZ
World J Gastroenterol; 2021 Sep; 27(35):5967-5977. PubMed ID: 34629813
[TBL] [Abstract] [Full Text] [Related]
5. Multidrug refractory aggressive metastatic tfe3 (+) renal cell carcinoma: A case report.
Paksoy N; Erdem S; Karaca M; Ak N; Pehlivan M; Yirgin IK; Ozluk Y; Ekiz F; Tural D; Ekenel M; Ozcan F; Basaran M
J Oncol Pharm Pract; 2022 Jan; 28(1):215-221. PubMed ID: 34134568
[TBL] [Abstract] [Full Text] [Related]
6. Laparoscopic resection of hepatic epithelioid hemangioendothelioma: report of eleven rare cases and literature review.
Xu J; Hu S; Li S; Wang W; Zhou X; Wu Y; Su Z; Cheng X; Gao Y; Zheng Q
World J Surg Oncol; 2020 Oct; 18(1):282. PubMed ID: 33121478
[TBL] [Abstract] [Full Text] [Related]
7. A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function.
Nam JY; Choe AR; Sinn DH; Lee JH; Kim HY; Yu SJ; Kim YJ; Yoon JH; Lee JM; Chung JW; Choi SY; Lee JK; Baek SY; Lee HA; Kim TH; Yoo K
BMC Cancer; 2020 Jun; 20(1):504. PubMed ID: 32487089
[TBL] [Abstract] [Full Text] [Related]
8. Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After Surgery.
He W; Peng B; Tang Y; Yang J; Zheng Y; Qiu J; Zou R; Shen J; Li B; Yuan Y
Clin Gastroenterol Hepatol; 2018 May; 16(5):756-764.e10. PubMed ID: 29246702
[TBL] [Abstract] [Full Text] [Related]
9. XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital.
Hung CC; Pan CC; Lin CC; Lin AT; Chen KK; Chang YH
J Chin Med Assoc; 2011 Nov; 74(11):500-4. PubMed ID: 22100019
[TBL] [Abstract] [Full Text] [Related]
10. Sunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinoma.
Liu YC; Chang PM; Liu CY; Yang CY; Chen MH; Pan CC; Chen MH
Jpn J Clin Oncol; 2011 Nov; 41(11):1277-81. PubMed ID: 21965162
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings.
Limouris GS; Dimitropoulos N; Kontogeorgakos D; Papanikolos G; Koutoulidis V; Hatzioannou A; Mourikis D; Lyra M; Dimitriou P; Stravaka A; Vlahos L
Cancer Biother Radiopharm; 2005 Apr; 20(2):215-7. PubMed ID: 15869458
[TBL] [Abstract] [Full Text] [Related]
